Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Ecancermedicalscience|June 15, 2022
The prevalence of cognitive impairment in older Indian persons with cancer and brain metastasesAditya Dhanawat, Vanita Noronha, Anant Ramaswamy, et al.
JCO Global Oncology|August 19, 2024
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study)Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, et al.
South Asian Journal of Cancer|December 22, 2025
High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival OutcomesNoorzia Syed, Anant Ramaswamy, Aditya Dhanawat, et al.
Ecancermedicalscience|January 21, 2026
Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinentAditya Dhanawat, Debdeep Samaddar, Bhagyashri Jadhav, et al.
JCO Global Oncology|July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western IndiaKunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
JTO Clinical and Research Reports|January 31, 2024
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLCVanita Noronha, Nandini S Menon, Vijay Maruti Patil, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
Pageof 2